Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Meningitis- creating bacteria: Weapons to destroy our immune system

Retrons- A new promising Gene-editing tool

Vaccination update: Pfizer allowed for emergency use in adolescents

Meningitis- creating bacteria: Weapons to destroy our immune system
  • BiotechToday
  • World

Meningitis- creating bacteria: Weapons to destroy our immune system

bioxone May 12, 2021May 11, 2021

Ayooshi Mitra, Amity University Kolkata

Meningitis is an inflammatory condition that affects the membranes that surround the brain and spinal cord. Viruses, bacteria, fungi, and parasites can all cause it. Bacterial meningitis is one of the most serious types, and it is a leading cause of death and disability in children all over the world. Several bacteria can cause the infection, including the respiratory pathogens Streptococcus pneumoniae and Haemophilus influenzae, which are responsible for approximately 200,000 meningitis-related deaths each year. These two bacteria frequently live in healthy people’s noses and throats without causing illness. They can spread into the bloodstream and cause invasive diseases in some cases, but the reasons for this are largely unknown.

A group of researchers at Sweden’s Karolinska Institutet discovered a mechanism to escape the immune system through meningitis-creating bacteria. In laboratory tests, they discovered that Streptococcus pneumoniae and Haemophilus influenzae respond to rising temperatures by producing defences that keep them alive. The researchers believe that this discovery will help us better understand the mechanisms that these bacteria use to evade our normal immune defences and will be an important piece of the puzzle in determining what turns this normally harmless bacterium into a lethal killer.

The researchers set out to investigate the relationship between temperature changes and the survival of these bacteria in a laboratory setting in this study. Another recent discovery linked the temperature sensing abilities of the bacterium N. meningitides to invasive meningococcal disease prompted the experiments. Elevated temperatures and fever are signs of infection, and they typically boost our immune system’s ability to fight illness. In this study, however, the researchers discovered that when exposed to higher temperatures, both S. pneumoniae, and H. influenzae activated stronger immune defences. They accomplished this via mechanisms involving four distinct RNA thermosensors (RNATs), which are temperature-sensitive non-coding RNA molecules. The RNATs helped generate considerably larger protective capsules as well as binding Factor H immune-modulatory proteins to prevent bacteria from attacking the immune system.

The study’s findings suggest that temperature sensing RNATs provide an extra layer of defence that aids bacteria in colonizing their natural habitat in the nose and throat. Interestingly, the researchers discovered that these RNATs have no sequence similarity, but all retain the same thermosetting ability, implying that these RNATs evolved independently to sense the same temperature cue in the nasopharynx to avoid immune killing. The researchers feel that further research in this field is needed to determine what causes these pathogens to breach the mucous membrane and enter the bloodstream and then the brain, and future research involving an in vivo infection model is needed to characterize the role of these RNATs during colonization and invasion. This research was published in the journal “PLoS Pathogens”.

Also read: Retrons- A new promising Gene-editing tool

Source:

Eichner H, Karlsson J, Spelmink L, Pathak A, Sham L-T, Henriques-Normark B, et al. (2021) RNA thermosensors facilitate Streptococcus pneumoniae and Haemophilus influenzae immune evasion. PLoSPathog 17(4): e1009513. https://doi.org/10.1371/journal.ppat.1009513

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged bacteria Brain Fungi immune system immunity infection influenza meningitis pathogens pneumonia RNATs thermosensors virus

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Vaccination update: Pfizer allowed for emergency use in adolescents

bioxone May 12, 2021

Camelia Bhattacharyya, Amity University Kolkata Amongst all the most awaited news, the updates on vaccination are the ones most wanted these days. People have finally become aware of the need for vaccination, and the number of anti-vaxxers has reduced. This has helped the medical community level up their reviews on saving lives, and information regarding […]

Pfizer

Related Post

  • World

Can mechanics be related to drug resistance?

bioxone September 21, 2020September 21, 2020

In the last decade it has been seen that cancer has become really widespread, yet it has got no complete treatment as such till date. However, the therapeutic approach “chemotherapy” has saved the lives of millions. With the advent of the concept of “chemotherapeutic resistance”, the progress in the field of treatment of cancer has […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Cancer therapy by targeting TGFβ signaling

bioxone January 15, 2021January 15, 2021

Souradip Mallick, National Institute of Technology, Rourkela Transforming growth factor-β (TGFβ) belongs to a multi-functional cytokine family comprising of different TGFβs, bone morphogenetic proteins, activins, growth differentiation factors, inhibins, and anti-Mullerian hormone. Members of this family regulate embryonic development, tissue homeostasis, and regeneration, and their malfunction has been implicated in cancer, fibrosis, immune diseases, and […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

Here’s how COVID-19 vaccine BNT162b1 produces human antibody and helper T-cell responses

bioxone October 4, 2020October 4, 2020

Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy